Want to join the conversation?
$CMTL posted lower earnings in 4Q16, hurt by higher expenses compared to 4Q15. Net income was $2.7MM or $0.14 per diluted share compared to $5.48MM or $0.34 per diluted share last year. Net sales were down from last year to $152.4MM. Adjusted EBITDA was $18.8MM in the quarter.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.